Cover Image
市場調查報告書

難辨梭狀芽孢桿菌傳染病(難辨梭狀芽孢桿菌相關疾病):全球臨床實驗趨勢

Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 320349
出版日期 內容資訊 英文 183 Pages
訂單完成後即時交付
價格
Back to Top
難辨梭狀芽孢桿菌傳染病(難辨梭狀芽孢桿菌相關疾病):全球臨床實驗趨勢 Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 183 Pages
簡介

難辨梭狀芽孢桿菌傳染病,是影響消化器官系統的細菌感染。最容易受到影響的是使用抗生素治療的人們。

本報告提供難辨梭狀芽孢桿菌傳染病(難辨梭狀芽孢桿菌相關疾病)的治療藥相關臨床實驗調查分析、臨床實驗數及被實驗人數、各階段及各方面狀況、有潛力的企業、開發中的治療藥的資訊、臨床實驗簡介等相關的系統性資訊。

本報告概要

各地區的難辨梭狀芽孢桿菌傳染病 (難辨梭狀芽孢桿菌相關疾病) 臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東、非洲的主要國家的臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗的難辨梭狀芽孢桿菌傳染病 (難辨梭狀芽孢桿菌相關疾病) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗的難辨梭狀芽孢桿菌傳染病 (難辨梭狀芽孢桿菌相關疾病) 的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商的各種類的臨床實驗數量

有潛力的贊助商

參與難辨梭狀芽孢桿菌傳染病 (難辨梭狀芽孢桿菌相關疾病) 治療藥臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4304CTIDB

GlobalData's clinical trial report, "Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2017" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 21
  • Clinical Trials by E7 Countries: Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials 23
  • Clinical Trials by Phase in E7 Countries 25
  • Clinical Trials in E7 Countries by Trial Status 26
  • Clinical Trials by Phase 27
  • In Progress Trials by Phase 28
  • Clinical Trials by Trial Status 29
  • Clinical Trials by End Point Status 31
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 33
  • Prominent Sponsors 34
  • Top Companies Participating in Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials 36
  • Prominent Drugs 38
  • Latest Clinical Trials News on Clostridium difficile Infections (Clostridium difficile Associated Disease) 40
  • Jul 03, 2017: Pre-Clinical Results of IMM-529 in C. difficile Infection Published in Scientific Reports 40
  • Jun 27, 2017: Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection 40
  • Jun 22, 2017: Summit Presents Data From Phase 1 Clinical Programme of Ezutromid at the European Paediatric Neurology Society Congress 41
  • Jun 12, 2017: Seres Therapeutics Initiates SER-109 Phase 3 Study in Patients with Multiply Recurrent C. difficile Infection 41
  • Jun 08, 2017: Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD 41
  • Jun 07, 2017: Rebiotix Data Presented at ASM Microbe 2017 Show RBX2660 Treated Patients Clinical Success Correlates with Improved Microbiome Diversity 42
  • Jun 06, 2017: Oragenics Presents Development of Novel Lantibiotic Against Clostridium difficile at the ICAAC Conference 42
  • Jun 05, 2017: Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017 42
  • Jun 01, 2017: Rebiotixs Phase 3-Ready RBX2660 to be Featured in Multiple Posters at ASM Microbe 2017 43
  • May 04, 2017: Rebiotix's Phase 3 ready RBX2660 to be Featured in Multiple Sessions at Digestive Disease Week 2017 43
  • May 02, 2017: Summit Therapeutics: Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases 44
  • Apr 28, 2017: Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summits Ridinilazole Achieved Statistical Superiority over Vancomycin in the Treatment of C. Difficile Infection 45
  • Apr 11, 2017: Rebiotix Reports Positive Top Line Data from Open-Label Phase 2 Trial of RBX2660 in Recurrent Clostridium difficile 45
  • Clinical Trial Profile Snapshots 47

Appendix 181

  • Abbreviations 181
  • Definitions 181
  • Research Methodology 182
  • Secondary Research 182
  • About GlobalData 183
  • Contact Us 183
  • Source 183

List of Tables

List of Tables

  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
  • Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 18
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 20
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 22
  • Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 24
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 25
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase, 2017* 27
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 39

List of Figures

List of Figures

  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 15
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
  • Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 17
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 23
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 25
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
  • Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
  • GlobalData Methodology 182
Back to Top